Article info

Download PDFPDF

P028 Treatment of BAFF transgenic mice with ANTI-TNF: monoclonal ANTI-TNF are associated with a higher risk of lymphoma than etanercept
Free

Authors

Citation

Nocturne G, Ly B, Boudaoud S, et al
P028 Treatment of BAFF transgenic mice with ANTI-TNF: monoclonal ANTI-TNF are associated with a higher risk of lymphoma than etanercept

Publication history

  • First published February 21, 2018.
Online issue publication 
February 21, 2018

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.